div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imagea href=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page1jpg target=_blank img data-url=crizotlnlb-atentionari-cu-crizotinib-peste-14700-de-pacienti-insuficientahtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5thumbnails1jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imagea href=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page2jpg target=_blank img data-url=crizotlnlb-atentionari-cu-crizotinib-peste-14700-de-pacienti-insuficientahtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5thumbnails2jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imagea href=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page3jpg target=_blank img data-url=crizotlnlb-atentionari-cu-crizotinib-peste-14700-de-pacienti-insuficientahtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5thumbnails3jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imagea href=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page4jpg target=_blank img data-url=crizotlnlb-atentionari-cu-crizotinib-peste-14700-de-pacienti-insuficientahtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader040vdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5thumbnails4jpg width=140 height=200 adivdiv